Abstracts tagged "epidemiologic methods and race/ethnicity"

Abstract Number: 2848 • 2018 ACR/ARHP Annual Meeting
Racial Disparities in Utilization of Knee Replacement: Data from the Osteoarthritis Initiative
Jie Wei^1,2, Chao Zeng^1,3, Uyen-Sa D.T. Nguyen⁴, Hyon K. Choi¹ and Yuqing Zhang⁵, ¹Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, ²Department of Health Management Center, Xiangya Hospital, Changsha, China, ³Department of Orthopedics, Xiangya Hospital, Changsha, China, ⁴Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ⁵Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA
Background/Purpose: While risk of knee osteoarthritis (OA) is higher among black than white individuals, the rate of knee replacement—an effective treatment for end-stage OA among…
Abstract Number: 876 • 2017 ACR/ARHP Annual Meeting
Epidemiologic Subsets Drive a Differentiated Clinical and Immunological Presentation of Primary Sjögren Syndrome: Analysis of 9302 Patients from the Big Data International Sjögren Cohort
Soledad Retamozo^1,2,3, Pilar Brito-Zerón^3,4, Margit Zeher⁵, Kathy L. Sivils⁶, Raphaele Seror⁷, Thomas Mandl⁸, Xiaomei Li⁹, Chiara Baldini¹⁰, Jacques-Eric Gottenberg¹¹, Debashish Danda¹², Roberta Priori¹³, Luca Quartuccio¹⁴, Gabriela Hernandez-Molina¹⁵, Aike A. Kruize¹⁶, Seung-Ki Kwok¹⁷, Marie Wahren-Herlenius¹⁸, Sonja Praprotnik¹⁹, Damien Sene²⁰, Roberto Gerli²¹, Roser Solans²², Yasunori Suzuki²³, David A. Isenberg²⁴, Maureen Rischmueller²⁵, Gunnel Nordmark²⁶, Guadalupe Fraile²⁷, Piotr Wiland²⁸, Hendrika Bootsma²⁹, Takashi Nakamura³⁰, Valeria Valim³¹, Roberto Giacomelli³², Valérie Devauchelle-Pensec³³, Benedikt Hofauer³⁴, Michele Bombardieri³⁵, Virginia Fernandes Moça Trevisani³⁶, Daniel S. Hammenfors³⁷, Steven E. Carsons³⁸, Sandra Gofinet Pasoto³⁹, Jacques Morel⁴⁰, Tamer Gheita⁴¹, Fabiola Atzeni⁴², Cristina F. Vollenweider⁴³, Belchin Kostov⁴⁴, Xavier Mariette⁴⁵ and Manuel Ramos-Casals⁴⁶, ¹Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, ²Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, ³Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, ⁴Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain, ⁵Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Debrecen, Hungary, ⁶Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁷Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France, Paris, France, ⁸Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, Lund, Sweden, ⁹Department of Rheumatology and Immunology, Anhui Medical University Affiliated Provincial Hospital, China, Hefei, Anhui, China, ¹⁰Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, ¹¹Department of Rheumatology, Strasbourg University Hospital, Université de Strasbourg, CNRS, Strasbourg, France, Strasbourg, France, ¹²Clinical Immunology & Rheumatology, Christian Medical College, Vellore, India, Vellore, India, ¹³UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Rome, Italy, ¹⁴Rheumatology Clinic, DSMB, University of Udine, Udine, Italy, Udine, Italy, ¹⁵Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición SZ, mexico city, Mexico, ¹⁶Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, ¹⁷[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), ¹⁸Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, ¹⁹Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ²⁰Service de Médecine Interne 2, Hôpital Lariboisière, Université Paris VII, Assistance Publique-Hôpitaux de Paris, 2, Paris, France, Paris, France, ²¹University and Azienda Ospedaliera of Perugia, Perugia, Italy, ²²Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, ²³Division of Rheumatology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan, Kanazawa, Japan, ²⁴Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, ²⁵Rheumatology, The Queen Elizabeth Hospital, South Australia, Adelaide, Australia, ²⁶Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden, Uppsala, Sweden, ²⁷Autoimmune Diseases Department, Hospital Ramón y Cajal, Madrid, Spain, ²⁸Department and Clinic of Rheumatology and Internal Medicine, Medical University, Wroclaw, Poland, ²⁹Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ³⁰Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, Nagasaki, Japan, ³¹Rheumatology, Department of Medicine, Universidade Federal do Espírito Santo, Vitória, Brazil, Vitória, Brazil, ³²University of L'Aquila, L'Aquila, Italy, ³³Department of Rheumatology, Brest University Hospital, Brest, France, ³⁴Hals-Nasen-Ohrenklinik und Poliklinik, Technische Universität München, München, Germany, München, Germany, ³⁵Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK, London, United Kingdom, ³⁶UNIFESP, Sao Paulo, Brazil, San Paulo, Brazil, ³⁷Department of Rheumatology, Haukeland University Hospital, University of Bergen, Bergen, Norway, ³⁸NYU Winthrop University Hospital, Department of Medicine, Mineola, NY, ³⁹Internal Medicine, Division of Rheumatology - Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, São Paulo, Brazil, ⁴⁰Department of Rheumatology, Teaching hospital and University of Montpellier, France, Montpellier, France, ⁴¹Rheumatology, Rheumatology Department, Faculty of Medicine, Cairo University, Egypt, Cairo, Egypt, ⁴²Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, ⁴³Rheumatology, German Hospital, Buenos Aires, Argentina, Buenos Aires, Argentina, ⁴⁴Primary Care Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Primary Care Centre Les Corts, CAPSBE, Barcelona, Spain, ⁴⁵Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France, ⁴⁶Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain
Background/Purpose: To analyse whether epidemiologic factors (such as gender or age at diagnosis of the disease) are associated with particular disease expressions and define some…
Abstract Number: 1482 • 2017 ACR/ARHP Annual Meeting
Preliminary Population-Based Incidence and Prevalence Estimates of Primary Sjogren’s Syndrome from the Manhattan Lupus Surveillance Program
Peter M. Izmirly¹, Isabella Wan², Sara Sahl³, Jill P. Buyon⁴, H. Michael Belmont⁵, Jane E. Salmon⁶, Anca Askanase⁷, Joan Bathon⁸, Laura Geraldino-Pardilla⁷, Yousaf Ali⁹, Ellen M. Ginzler¹⁰, Chaim Putterman¹¹, Caroline Gordon¹², Charles G. Helmick¹³ and Hilary Parton¹⁴, ¹Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ²Medicine/Rheumatology, New York University School of Medicine, New York, NY, ³Pediatrics, Harbor-University of California at Los Angeles Medical Center, Torrance, CA, ⁴Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁵Medicine, New York University School of Medicine, New York, NY, ⁶Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, ⁷Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, ⁸Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ⁹Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, ¹⁰Rheumatology, Division of Rheumatology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, ¹¹Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY, ¹²Rheumatology Research Group, Institute of Inflammation and Ageing,, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ¹³Centers for Disease Control and Prevention, Atlanta, GA, ¹⁴Bureau of Epidemiology Services, New York City Department of Health and Mental Hygiene, Long Island City, NY
Background/Purpose: The extant epidemiologic data of Primary Sjögren’s Syndrome (pSS) remains limited with few published estimates for the general population and little data regarding racial/ethnic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].